In Vivo CAR-M Program
B-cell driven autoimmune diseases / Hematologic cancers
PreclinicalActive
Key Facts
Indication
B-cell driven autoimmune diseases / Hematologic cancers
Phase
Preclinical
Status
Active
Company
About Liberate Bio
Liberate Bio is a private, preclinical-stage biotech founded in 2021 and based in San Diego, CA. The company is pioneering a novel delivery platform, RAPTOR™, to enable in vivo genetic medicines for diseases driven by cells outside the liver, with an initial focus on hematologic cancers and autoimmune disorders. Backed by Khosla Ventures and led by a team with deep expertise in delivery and genetic medicine, Liberate has demonstrated proof-of-concept in non-human primates and is advancing its first pipeline programs. Its business model is therapeutics-focused, aiming to develop and commercialize its own drug candidates.
View full company profile